Patents Assigned to Astrocyte Pharmaceuticals, Inc.
  • Compounds and methods for treating addiction and related disorders
    Patent number: 11839615
    Abstract: The present invention relates to adenosine receptor agonist compounds and methods of use thereof for treatment of certain disorders and conditions, for example an addiction or compulsive disorder. Exemplary compounds for use in disclosed methods include: and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: February 8, 2019
    Date of Patent: December 12, 2023
    Assignees: Astrocyte Pharmaceuticals, Inc., The Board of Regents of the University of Texas System
    Inventors: William S. Korinek, Theodore E Liston, James D. Lechleiter, Michael Beckstead
  • Compounds and methods for treating neurological and cardiovascular conditions
    Patent number: 11484545
    Abstract: The present invention relates to compounds and methods of use thereof for treatment of certain disorders and conditions, for example brain injuries such as stroke or traumatic brain injuries.
    Type: Grant
    Filed: February 19, 2021
    Date of Patent: November 1, 2022
    Assignees: Astrocyte Pharmaceuticals, Inc., The Board of Regents of the University of Texas System
    Inventors: William S. Korinek, James D. Lechleiter, Theodore E. Liston
  • Polymorphic compounds and uses thereof
    Patent number: 11324769
    Abstract: The present invention provides compounds and methods of use thereof for treatment of certain disorders and conditions, for example brain injuries such as stroke or traumatic brain injuries.
    Type: Grant
    Filed: July 28, 2020
    Date of Patent: May 10, 2022
    Assignee: Astrocyte Pharmaceuticals, Inc.
    Inventors: Russell Birch Poe, David T. Jonaitis, Lisa Michelle Grove
  • Compounds and methods for treating neurological and cardiovascular conditions
    Patent number: 10953031
    Abstract: The present invention relates to compounds and methods of use thereof for treatment of certain disorders and conditions, for example brain injuries such as stroke or traumatic brain injuries.
    Type: Grant
    Filed: March 14, 2019
    Date of Patent: March 23, 2021
    Assignees: Astrocyte Pharmaceuticals, Inc., The Board of Regents of the University of Texas System
    Inventors: William S. Korinek, James D. Lechleiter, Theodore E. Liston
  • Polymorphic compounds and uses thereof
    Patent number: 10765693
    Abstract: The present invention provides compounds and methods of use thereof for treatment of certain disorders and conditions, for example brain injuries such as stroke or traumatic brain injuries.
    Type: Grant
    Filed: September 26, 2019
    Date of Patent: September 8, 2020
    Assignee: Astrocyte Pharmaceuticals, Inc.
    Inventors: Russell Birch Poe, David T. Jonaitis, Lisa Michelle Grove
  • Compounds and methods for treating neurological and cardiovascular conditions
    Patent number: 10265338
    Abstract: The present invention relates to compounds and methods of use thereof for treatment of certain disorders and conditions, for example brain injuries such as stroke or traumatic brain injuries.
    Type: Grant
    Filed: August 7, 2017
    Date of Patent: April 23, 2019
    Assignees: ASTROCYTE PHARMACEUTICALS, INC., THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEMS
    Inventors: William S. Korinek, James D. Lechleiter, Theodore E. Liston
  • Compounds and methods for treating neurological and cardiovascular conditions
    Patent number: 9789131
    Abstract: The present invention relates to compounds and methods of use thereof for treatment of certain disorders and conditions, for example brain injuries such as stroke or traumatic brain injuries.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: October 17, 2017
    Assignees: Astrocyte Pharmaceuticals, Inc., The Board of Regents of the University of Texas System
    Inventors: William S. Korinek, James D. Lechleiter, Theodore E. Liston